Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
Anticancer Research · 2023
DOI: 10.21873/anticanres.16280 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Anticancer Research, 2023. Verfasst von Akihiro Tamiya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kinki-Chuo Chest Medical Center, Sakai, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Kinki-Chuo Chest Medical Center, Sakai, Japan.
- Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan; moto19781205@yahoo.co.jp.
- Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Clinical Research Center, Kinki-Chuo Chest Medical Center, Sakai, Japan.
Zitieren
APA
Tamiya, A., Tamiya, M., Inagaki, Y., Taniguchi, Y., Nakao, K., Matsuda, Y., Kawamura, T., Kunimasa, K., Inoue, T., Nishino, K., & Okishio, K. (2023). Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting. Anticancer Research. https://doi.org/10.21873/anticanres.16280
Vancouver
Tamiya A, Tamiya M, Inagaki Y, Taniguchi Y, Nakao K, Matsuda Y, et al. Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting. Anticancer Research. 2023. doi:10.21873/anticanres.16280
BibTeX
@article{Tamiya2023,
author = {Tamiya, Akihiro and Tamiya, Motohiro and Inagaki, Yuji and Taniguchi, Yoshihiko and Nakao, Keiko and Matsuda, Yoshinobu and Kawamura, Takahisa and Kunimasa, Kei and Inoue, Takako and Nishino, Kazumi and Okishio, Kyoichi},
title = {Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16280}
}
EUVIMED